Want to join the conversation?
Pharmaceutical company $AKRX said it has received a notice from the Nasdaq Listing Qualifications Staff stating that the company is not in compliance with Nasdaq's rule on timely filing of its 2015 Form 10-K with the SEC by Feb. 29, 2016. $AKRX expects to file the report with the SEC by the May 9 extension granted by the Nasdaq Stock Market.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.